Nitric oxide downregulates tumour necrosis factor mRNA in RAW 264.7 cells

Research in Immunology

Volumn 149, Issue 2, 1998, Pages 139-150

  Sinha, B ^a,b   Eigler, A ^a   Baumann, K H ^a   Greten, T F ^a   Moeller, J ^a   Endres, S ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Half life; Immunoregulation; L arginine; Macrophage; MRNA; NO; RAW 264.7 cell line; TNF

Indexed keywords

ARGININE; CITRULLINE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME SUBSTRATE; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPTIC SHOCK;

EID: 0032007485     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(98)80297-6     Document Type: Article

References (53)

1. Änggård, E. (1994), Nitric oxide: mediator, murderer, and medicine. Lancet, 343, 1199-1206.
2. Beutler, B. & Cerami, A. (1989), The biology of cachectin/TNF - a primary mediator of the host response. Annu. Rev. Immunol., 7, 625-655.
3. Beutler, B., Krochin, N., Milsark, I.W., Luedke, C. & Cerami, A. (1986), Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science, 232, 977-980.
4. Beutler, B., Thompson, P., Keyes, J., Hagerty, K. & Crawford, D. (1988), Assay of a ribonuclease that preferentially hydrolyses mRNAs containing cytokine-derived UA-rich instability sequences. Biochem. Biophys. Res. Commun., 152, 973-980.
5. Beutler, E., Gelbart, T., Han, J., Koziol, J.A. & Beutler, B. (1989), Evolution of the genome and the genetic code: selection at the dinucleotide level by methylation an polyribonucleotide cleavage. Proc. Natl. Acad. Sci. USA, 86, 192-196.
6. Bouma, M.G., Stad, R.K., van den Wildenberg, F.A. & Buurman, W.A. (1994), Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J. Immunol., 153, 4159-4168.
7. Caput, D., Beutler, B., Hartog, K., Thayer, R., Brown-Shimer, S. & Cerami, A. (1986), Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA, 83, 1670-1674.
8. Chomczynski, P. & Sacchi, N. (1987), Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal. Biochem., 162, 156-159.
9. Collart, M.A., Baeuerle, P. & Vassalli, P. (1990), Regulation of tumor necrosis factor alpha transcription in macrophages : involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol. Cell. Biol., 10, 1498-1506.
10. De Caterina, R., Libby, P., Peng, H.-B., Thannickal, V.J., Rajavashisth, T.B., Gimbrone, M.A., Shin, W.S. & Liao, J. (1995), Nitric oxide decreases cytokine-induced endothelial activation. J. Clin. Invest., 96, 60-68.
11. Eigler, A., Greten, T.F., Sinha, B., Haslberger, C., Sullivan, G.W. & Endres, S. (1997a), Endogenous adenosine curtails lipopolysaccharide-stimulated tumour necrosis factor synthesis. Scand. J. Immunol., 45, 132-139.
12. Eigler, A., Moeller, J. & Endres, S. (1995), Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line RAW 264.7. J. Immunol., 154, 4048-4054.
13. Eigler, A., Sinha, B. & Endres, S. (1993), Nitric oxide-releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear cells. Biochem. Biophys. Res. Commun., 196, 494-501.
14. Eigler, A., Sinha, B., Hartmann, G. & Endres, S. (1997b), Taming TNF: strategies to restrain this proinflammatory cytokine. Immunol. Today, 18, 487-492.
15. Endres, S., Fülle, H.J., Sinha, B., Stoll, D., Dinarello, C.A., Gerzer, R. & Weber, P.C. (1991), Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-alpha and interleukin-1 beta by human mononuclear cells. Immunology, 72, 56-60.
16. Florquin, S., Amraoui, Z., Dubois, C., Decuyper, J. & Goldman, M. (1994), The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice. J. Exp. Med., 180, 1153-1158.
17. Fransen, L., Müller, R., Marmenout, A., Tavernier, J., van der Heyden, J., Kawashima, E., Chollet, A., Tizard, R., van Heuverswyn, H., van Vliet, A., Ruysschaert, M.-R. & Fiers, W. (1985), Molecular cloning of mouse tumor necrosis factor cDNA and its eukaryotic expression. Nucleic Acids Res., 13, 4417-4429.
18. Fukatsu, K., Saito, H., Fukushima, R., Inoue, T., Lin, M.T., Inaba, T. & Muto, T. (1995), Detrimental effects of a nitric oxide synthase inhibitor (N-omega-nitro-L-arginine-methyl-ester) in a murine sepsis model. Arch. Surg., 130, 410-414.
19. Fülle, H.J., Endres, S., Sinha, B., Stoll, S., Weber, P.C. & Gerzer, R. (1991), Effects of SIN-1 on cytokine synthesis in human mononuclear cells. J. Cardiovasc. Pharmacol., 17, 113-116.
20. Goldfeld, A.E., Doyle, C. & Maniatis, T. (1990), Human tumor necrosis factor alpha gene regulation by virus and lipopolysaccharide. Proc. Natl. Acad. Sci. USA, 87, 9769-9773.
21. Green, L.C., Wagner, D.A., Glogowski, J.S., Skipper, P.L., Wishnok, J.S. & Tannenbaum, S.R. (1982), Analysis of nitrate, nitrite and [15-N]nitrite in biological fluids. Anal. Biochem., 126, 131-138.
22. Greten, T., Eigler, A., Sinha, B., Moeller, J. & Endres, S. (1995), The specific type IV phosphodiesterase inhibitor rolipram differentially regulates the proinflammatory mediators TNF-α and nitric oxide. Int. J. Immunopharmacol., 17, 605-610.
23. Haas, J.G., Baeuerle, P.A., Riethmüller, G. & Ziegler-Heitbrock, H.W.L. (1990), Molecular mechanisms in down-regulation of tumor necrosis factor expression. Proc. Natl. Acad. Sci. USA, 87, 9563-9567.
24. Han, J., Brown, T. & Beutler, B. (1990a), Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level [published erratum appears in J. Exp. Med., 1990, Mar 1;171(3):971-2]. J. Exp. Med., 171, 465-475.
25. Han, J., Thompson, P. & Beutler, B. (1990b), Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J. Exp. Med., 172, 391-394.
26. Hattori, Y., Campbell, E.B. & Gross, S.S. (1994), Argininosuccinate synthetase messenger RNA and activity are induced by immunostimulants in vascular smooth muscle - role in the regeneration of arginine for nitric oxide synthesis. J. Biol. Chem., 269, 9405-9408.
27. Koide, M., Kawahara, Y., Nakayama, I., Tsuda, T. & Yokoyama, M. (1993), Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells - synergism with the induction elicited by inflammatory cytokines. J. Biol. Chem., 268, 24959-24966.
28. Liebermann, A.P., Pitha, P.M. & Shin, M.L. (1992), Poly(A) removal is the kinase-regulated step in tumor necrosis factor mRNA decay. J. Biol. Chem., 267, 2123-2126.
29. Lowenstein, C.J., Glatt, C.S., Bredt, D.S. & Snyder, S.H. (1992), Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc. Natl. Acad. Sci. USA, 89, 6711-6715.
30. Lowenstein, C.J. & Snyder, S.H. (1992), Nitric oxide, a novel biologic messenger. Cell, 70, 705-707.
31. MacMicking, J.D., Nathan, C., Hom, G., Chartrain, N., Fletcher, D.S., Trumbauer, M., Stevens, K., Xie, Q., Sokol, K., Hutchinson, N., Chen, H. & Mudgett, J.S. (1995), Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell, 81, 641-650.
32. McGeehan, G.M., Becherer, J.D., Bast, R.C.J., Boyer, C.M., Champion, B., Conolly, K.M., Convay, J.G., Furdon, P., Karp, S., Kidao, S., McElroy, A.B., Nichols, J., Pryzwansky, K.M., Schoenen, F., Sekut, L., Truesdale, A., Verghese, M., Warner, J. & Ways, J.P. (1994), Regulation of tumour necrosis factor-α by a metalloproteinase inhibitor. Nature, 370, 558-561.
33. Mohler, K.M., Sleath, P.R., Fitzner, J.N., Ceretti, D.P., Alderson, M., Kerwar, S.S., Torrance, D.S., Otten-Evans, C., Greenstreet, T., Weerawarna, K., Krohnheim, S.R., Petersen, M., Gerhart, M., Kozlosky, C.J., March, C.J. & Black, R.A. (1994), Protection against a lethal dose of endotoxin by an inhibitor of tumor necrosis factor processing. Nature, 370, 218-220.
34. Moncada, S. & Higgs, A. (1993), The L-arginine-nitric oxide pathway. N. Engl. J. Med., 329, 2002-2012.
35. Moreira, A.L., Sampaio, E.P., Zmuidzinas, A., Frindt, P., Smith, K.A. & Kaplan, G. (1993), Thalidomide exerts its inhibitory action on tumor necrosis factor-alpha by enhancing messenger RNA degradation. J. Exp. Med., 177, 1675-1680.
36. Mossman, T. (1983), Rapid colorimetric assay for cellular growth and survival; application to proliferation and cytotoxicity assays. J. Immunol., 65, 55-63.
37. Nathan, C. (1992), Nitric oxide as a secretory product of mammalian cells. FASEB J., 6, 3051-3064.
38. Nussler, A.K., Billiar, T.R., Liu, Z.-Z. & Morris, S.M.J. (1994), Coinduction of nitric oxide synthase and argininosuccinate synthetase in a murine macrophage cell line. Implications for regulation of nitric oxide production. J. Biol. Chem., 269, 1257-1261.
39. Parmely, M.J., Zhou, W.W., Edwards, C.K., Borcherding, D.R., Silverstein, R. & Morrison, D.C. (1993), Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge. J. Immunol., 151, 389-396.
40. Reiling, N., Ulmer, A.J., Duchrow, M., Ernst, M., Flad, H.D. & Hauschildt, S. (1994), Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur. J. Immunol., 24, 1941-1944.
41. Sambrook, J., Fritsch, E.F. & Maniatis, T. (1989), Molecular cloning: a laboratory handbook. Cold Spring Harbor Laboratory Press, New York.
42. Sariban, E., Imamura, K., Luebbers, R. & Kufe, D. (1988), Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes. J. Clin. Invest., 81, 1506-1510.
43. Semon, D., Kawashima, E., Jongeneel, C.V., Shakhov, A.N. & Nedospasov, S.A. (1987), Nucleotide sequence of the murine TNF locus, including the TNF-α (tumor necrosis factor) and TNF-β (lymphotoxin) genes. Nucleic Acids Res., 15, 9083-9084.
44. Shaw, G. & Kamen, R. (1986), A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell, 46, 659-667.
45. Sinha, B., Semmler, J., Eisenhut, T., Eigler, A. & Endres, S. (1995), Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phophodiesterase inhibitors and prostanoids. Eur. J. Immunol., 25, 147-153.
46. Tannenbaum, C.S. & Hamilton, T.A. (1989), Lipopolysaccharide-induced gene expression in murine peritoneal macrophages is selectively suppressed by agents that elevate intracellular cAMP. J. Immunol., 142, 1274-1280.
47. Tiao, G., Rafferty, J., Ogle, C., Fischer, J.E. & Hasselgreen, P.-O. (1994), Detrimental effect of nitric oxide synthase inhibition during endotoxemia may be caused by high levels of tumor necrosis factor and interleukin-6. Surgery, 116, 332-338.
48. Tracey, K.J. & Cerami, A. (1994), Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu. Rev. Med., 45, 491-503.
49. Van Dervort, A.L., Yan, L., Madara, P.J., Cobb, J.P., Wesley, R.A., Corriveau, C.C., Tropea, M.M. & Danner, R.L. (1994), Nitric oxide regulates endotoxin-induced TNF-alpha production by human neutrophils. J. Immunol., 152, 4102-4109.
50. Wu, G. & Brosnan, J.T. (1992), Macrophages can convert citrulline into arginine. Biochem. J., 281, 45-48.
51. Xie, Q.W., Cho, H.J., Calaycay, J., Mumford, R.A., Swiderek, K.M., Lee, T.D., Ding, A., Troso, T. & Nathan, C. (1992), Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science, 256, 225-228.
52. Ziegler-Heitbrock, H.W.L., Sternsdorf, T., Liese, J., Belohradsky, B., Weber, C., Wedel, A., Schreck, R., Baeuerle, P. & Strobel, M. (1993), Pyrrolidine dithiocarbamate inhibits NF-κ B mobilization and TNF production in human monocytes. J. Immunol., 151, 6986-6993.
53. Zinetti, M., Fantuzzi, G., Delgado, R., Di Santo, E., Ghezzi, P. & Fratelli, M. (1995), Endogenous nitric oxide production by human monocytic cells regulates LPS-induced TNF production. Eur. Cytokine Netw., 6, 45-48.